Provided by Tiger Fintech (Singapore) Pte. Ltd.

Merck

82.74
+2.903.63%
Pre-market: 82.980.2400+0.29%05:22 EDT
Volume:28.38M
Turnover:2.31B
Market Cap:208.21B
PE:12.03
High:83.28
Open:80.17
Low:78.06
Close:79.84
Loading ...

Amgen, Merck Share Losses Contribute To Dow's 262-Point Drop

Dow Jones
·
09 Apr

Major Pharma Stocks Down Amid Tariff Turmoil

MT Newswires Live
·
09 Apr

Merck, Goldman Sachs Share Losses Lead Dow's 166-Point Fall

Dow Jones
·
09 Apr

Shares of Drugmakers Down After Trump Threatens Tariffs on Sector

THOMSON REUTERS
·
09 Apr

Morgan Stanley Sticks to Its Hold Rating for Merck & Company (MRK)

TIPRANKS
·
09 Apr

Theratechnologies Reports Financial Results for the First Quarter 2025 and Reviews Key Achievements

GlobeNewswire
·
09 Apr

BUZZ-US drugmakers fall as Trump threatens tariffs again

Reuters
·
09 Apr

Gilead Sciences Down 3%, Amgen Down 2.9%, Pfizer Down 2.7%

THOMSON REUTERS
·
09 Apr

Drugmakers Down Premarket After Trump Threatens Tariffs on Sector

THOMSON REUTERS
·
09 Apr

Pharma Stocks Sink After Trump Says "Major" Tariffs Are Coming

Tiger Newspress
·
09 Apr

Pharma Stocks Tumble After Trump Threatens Tariffs on Medicines

Dow Jones
·
09 Apr

BUZZ-European healthcare drops as Trump says tariffs on sector coming soon

Reuters
·
09 Apr

Merck & Co., Inc. (MRK): Among Defensive Stocks Billionaire Ken Fisher is Betting On

Insider Monkey
·
09 Apr

Apple, Nike Share Losses Lead Dow's 250-Point Fall

Dow Jones
·
09 Apr

Theratechnologies Gets FDA Approval for Prior Approval Supplement of Abdominal Fat Reduction Treatment

MT Newswires Live
·
08 Apr

Theratechnologies Receives FDA Approval for EGRIFTA SV

MT Newswires
·
08 Apr

Theratechnologies Receives FDA Approval of Prior Approval Supplement (PAS) for EGRIFTA SV® sBLA

GlobeNewswire
·
08 Apr

Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment

StockStory
·
08 Apr

Hengrui Medicine Grants Merck Licensing Rights to Fertility Drug

MT Newswires Live
·
08 Apr

2 Reasons to Like MRK (and 1 Not So Much)

StockStory
·
07 Apr